跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 97 条关于
“Psyros”
全部
97
临床试验
56
药物
17
机构
4
资讯
20
11天前
Prolight Signs USD 3.9 Million Supply Agreement with BRAINBox for TBI Point-of-Care Diagnostics
2个月前
G&H to Showcase Integrated Diagnostic Device Development and Manufacturing Capabilities at ADLM 2026
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
Syros Pharmaceuticals Announces SELECT-MDS-1 Trial Update and Strategic Realignment
3年前
Syros Pharmaceuticals Advances Clinical Programs in MDS, AML, and APL
去年
Syros' Tamibarotene Fails Phase III Trial in MDS Patients
去年
Syros Pharma's Tamibarotene Fails in Phase III MDS Trial, Stock Plummets
去年
Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals for ADPKD Development
去年
Syros' Tamibarotene Fails Phase III Trial in Higher-Risk Myelodysplastic Syndrome
去年
Syros' Tamibarotene Fails in Phase III Trial for Higher-Risk Myelodysplastic Syndrome
第 1 页,共 2 页
上一页
下一页